Phase 1 | Central Kentucky Research
AMR performs phase I, II, III, and IV clinical research trials to support pharmaceutical companies in the development of new drugs, devices, and vaccines at 17 locations across the United States. Over 24 years ago, AMR owners began collaborating based on their mutual respect and shared values. Relationships are the foundation of AMR’s success. Our flexible solutions propel clinical trials from ideas to reality through relationships with industry experts you know. To learn more about AMR’s fully integrated network, click here: amrllc.com.

Phase 1

CKRA is proud to announce the opening of our brand new Phase I/IIa In-House Facility. The Unit encompasses 5,000 square feet adjacent to our Lexington research office that is dedicated to completing healthy volunteer and special population early phase trials. Each of the 10 private rooms is equipped with a queen bed, private bath, recliner and flat screen cable DVD/TV. Six of the 10 rooms are fully handicap accessible. The entertainment lounge offers cable TV, available WiFi, DVD and book libraries and game tables, ensuring the comfort of CKRA’s volunteers, which increases compliance and reduces drop out rates. CKRA currently maintains a healthy volunteer database of over 1,200 patients as well as having access to various patient populations across a range of therapeutic areas. This new early phase unit enhances CKRA’s commitment to advancing pharmaceutical research. CKRA is not under the jurisdiction of a local Institutional Review Board (IRB) and must use a Central IRB. Some Central IRBs utilized are: SAIRB, WIRB, NEIRB, RCRC, Quorum, Essex , Copernicus, Goodwyn, Lee Coast and Chesapeake .

[anything_slides cat=phase-i]